123 related articles for article (PubMed ID: 33241486)
1. Shear-Thinning Viscous Materials for Subconjunctival Injection of Microparticles.
Xia S; Ding Z; Luo L; Chen B; Schneider J; Yang J; Eberhart CG; Stark WJ; Xu Q
AAPS PharmSciTech; 2020 Nov; 22(1):8. PubMed ID: 33241486
[TBL] [Abstract][Full Text] [Related]
2. In vivo evaluation of solid lipid microparticles and hybrid polymer-lipid microparticles for sustained delivery of leuprolide.
Wu C; Luo X; Baldursdottir SG; Yang M; Sun X; Mu H
Eur J Pharm Biopharm; 2019 Sep; 142():315-321. PubMed ID: 31299277
[TBL] [Abstract][Full Text] [Related]
3. Modulating protein release profiles by incorporating hyaluronic acid into PLGA microparticles Via a spray dryer equipped with a 3-fluid nozzle.
Wan F; Maltesen MJ; Andersen SK; Bjerregaard S; Baldursdottir SG; Foged C; Rantanen J; Yang M
Pharm Res; 2014 Nov; 31(11):2940-51. PubMed ID: 24867422
[TBL] [Abstract][Full Text] [Related]
4. Formation Mechanism, In vitro and In vivo Evaluation of Dimpled Exenatide Loaded PLGA Microparticles Prepared by Ultra-Fine Particle Processing System.
Zhu C; Peng T; Huang D; Feng D; Wang X; Pan X; Tan W; Wu C
AAPS PharmSciTech; 2019 Jan; 20(2):64. PubMed ID: 30627822
[TBL] [Abstract][Full Text] [Related]
5. Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model.
Ayalasomayajula SP; Kompella UB
Eur J Pharmacol; 2005 Mar; 511(2-3):191-8. PubMed ID: 15792788
[TBL] [Abstract][Full Text] [Related]
6. Drug micro-carriers with a hyaluronic acid corona toward a diffusion-limited aggregation within the vitreous body.
Mayol L; Silvestri T; Fusco S; Borzacchiello A; De Rosa G; Biondi M
Carbohydr Polym; 2019 Sep; 220():185-190. PubMed ID: 31196539
[TBL] [Abstract][Full Text] [Related]
7. Self-implanted tiny needles as alternative to traditional parenteral administrations for controlled transdermal drug delivery.
Chen BZ; Yang Y; Wang BB; Ashfaq M; Guo XD
Int J Pharm; 2019 Feb; 556():338-348. PubMed ID: 30553955
[TBL] [Abstract][Full Text] [Related]
8. Sunitinib malate-loaded biodegradable microspheres for the prevention of corneal neovascularization in rats.
Yang J; Luo L; Oh Y; Meng T; Chai G; Xia S; Emmert D; Wang B; Eberhart CG; Lee S; Stark WJ; Ensign LM; Hanes J; Xu Q
J Control Release; 2020 Nov; 327():456-466. PubMed ID: 32822742
[TBL] [Abstract][Full Text] [Related]
9. Porous silicon oxide-PLGA composite microspheres for sustained ocular delivery of daunorubicin.
Nan K; Ma F; Hou H; Freeman WR; Sailor MJ; Cheng L
Acta Biomater; 2014 Aug; 10(8):3505-12. PubMed ID: 24793657
[TBL] [Abstract][Full Text] [Related]
10. Development of a sustained-release system for perivascular delivery of dipyridamole.
Zhu W; Masaki T; Bae YH; Rathi R; Cheung AK; Kern SE
J Biomed Mater Res B Appl Biomater; 2006 Apr; 77(1):135-43. PubMed ID: 16206204
[TBL] [Abstract][Full Text] [Related]
11. Electron dispersive X-ray spectroscopy and degradation properties of hyaluronic acid decorated microparticles.
Serri C; Frigione M; Ruponen M; Urtti A; Borzacchiello A; Biondi M; Itkonen J; Mayol L
Colloids Surf B Biointerfaces; 2019 Sep; 181():896-901. PubMed ID: 31382338
[TBL] [Abstract][Full Text] [Related]
12. Design and development of a novel controlled release PLGA alginate-pectinate polyspheric drug delivery system.
Sweet JL; Pillay V; Choonara YE
Drug Deliv; 2007 Jul; 14(5):309-18. PubMed ID: 17613019
[TBL] [Abstract][Full Text] [Related]
13. Subconjunctival injection of rapamycin-loaded polymeric microparticles for effective suppression of noninfectious uveitis in rats.
Mo L; Deng M; Chen J; Huai S; Du L; Xu X; Guo Q; Chen H; Li X; Bao Z
Int J Pharm; 2024 May; 657():124178. PubMed ID: 38692499
[TBL] [Abstract][Full Text] [Related]
14. Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitis.
Luo L; Yang J; Oh Y; Hartsock MJ; Xia S; Kim YC; Ding Z; Meng T; Eberhart CG; Ensign LM; Thorne JE; Stark WJ; Duh EJ; Xu Q; Hanes J
J Control Release; 2019 Feb; 296():68-80. PubMed ID: 30660629
[TBL] [Abstract][Full Text] [Related]
15. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.
Amrite AC; Ayalasomayajula SP; Cheruvu NP; Kompella UB
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1149-60. PubMed ID: 16505053
[TBL] [Abstract][Full Text] [Related]
16. Sustained delivery of vascular endothelial growth factor using a dextran/poly(lactic-co-glycolic acid)-combined microsphere system for therapeutic neovascularization.
Zhang ZD; Xu YQ; Chen F; Luo JF; Liu CD
Heart Vessels; 2019 Jan; 34(1):167-176. PubMed ID: 30043157
[TBL] [Abstract][Full Text] [Related]
17. Modification of biodegradable poly(malate) and poly(lactic-co-glycolic acid) microparticles with low molecular polyethylene glycol.
Yoncheva K; Lambov N; Miloshev S
Drug Dev Ind Pharm; 2009 Apr; 35(4):449-54. PubMed ID: 19288298
[TBL] [Abstract][Full Text] [Related]
18. Biodegradable microparticles designed to efficiently reach and act on cystic fibrosis mucus barrier.
Cristallini C; Barbani N; Ventrelli L; Summa C; Filippi S; Capelôa T; Vitale E; Albera C; Messore B; Giachino C
Mater Sci Eng C Mater Biol Appl; 2019 Feb; 95():19-28. PubMed ID: 30573241
[TBL] [Abstract][Full Text] [Related]
19. In vitro drug release behavior, mechanism and antimicrobial activity of rifampicin loaded low molecular weight PLGA-PEG-PLGA triblock copolymeric nanospheres.
Gajendiran M; Divakar S; Raaman N; Balasubramanian S
Curr Drug Deliv; 2013 Dec; 10(6):722-31. PubMed ID: 23701139
[TBL] [Abstract][Full Text] [Related]
20. Highly bioactive, bevacizumab-loaded, sustained-release PLGA/PCADK microspheres for intravitreal therapy in ocular diseases.
Liu J; Li S; Li G; Li X; Yu C; Fu Z; Li X; Teng L; Li Y; Sun F
Int J Pharm; 2019 May; 563():228-236. PubMed ID: 30959236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
